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Summary.-AKR mice, which have a short mean survival time and usually die with
leukaemia, were studied from one month of age for correlation between these two
parameters. For untreated animals we found the same mean survival time whether
or not leukaemia occurred. By treating sucklings with the polycations diethylamino-
ethyl-dextran or hexadimethrine bromide the leukaemia incidence was significantly
reduced. However, the mean survival time was unchanged, and remained the same in
leukaemic and non-leukaemic animals. It is therefore suggested that the early death
of AKR mice results from an ageing process and does not require leukaemia for
implementation. Our prophylactic polycation treatment was furthermore found to
induce spleen amyloid in some but not all of the mice that remained non-leukaemic.
THE short mean survival time of AKR
mice is generally attributed to the leu-
kaemia which develops in most animals
before death. However, we observed
(Ebbesen, 1972) that prophylactic treat-
ment of young non-leukaemic AKR mice
with the amyloidogenic compound casein
reduced the incidence ofleukaemia without
significant effect on mean survival time.
As this raises the possibility that there is a
hitherto unrecognized mechanism which
ensures the early death of most animals
irrespective of leukaemia, we have again
looked into the mean survival timeofAKR
mice. Those dying without evidence of
leukaemia have been compared with those
dying with leukaemia in a group of un-
treated mice, and in two experiments
intended to reduce the incidence of
leukaemia.
MATERIALS AND METHODS
Animals.-Inbred AKR mice (Staats, 1972)
originally obtained from Furth, and since
1958 maintained at theStatens Seruminstitut,
Copenhagen, were used in 3 separate experi-
ments.
Chemicals8.-Diaminoethyl-dextran
(DEAE-d) mol. wt 2x 106, dextran mol. wt
5x 105 and dextran sulphate mol. wt 5x 105
from Pharmacia, Sweden, and polybrene
mol. wt 3600 from Abbott Lab., Milwaukee,
were made up in minimum essential medium
(Eagle's MEM) with Hanks' balanced salt
solution pH 7-2 and filtered (0-45 ,um
pore size).
Treatment ofmice.-Polyion treatment was
done by i.p. inoculation of 25, 50, 250 and
1000 jug on Days 1, 7, 14 and 28 after birth,
respectively. In addition, one group in a
repeat experiment received 2-5, 5, 25 and 100
,ug DEAE-d. Treatment of AKR mice with
syngeneic lymphoid cells throughout life was
carried out by monthly i.p. inoculations of
cells from 1 month of age. A monocellular
suspension was made of 1-month-old AKR
thymus, spleen, lymph node, buffy coat and
bone marrow, and 108 cells from one donor
were inoculated into only one AKR recipient.
In all test groups, as well as in uninoculated
litters, there was a 20% mortality during the
first month; these early deaths were excluded
from the material. When 4 weeks old, the
sexes were segregated; animals were kept for
life, inspected 6 days a week and killed, very
ill, shortly before they were expected to die.
At necropsy, leucocyte counts and haemato-
crit values were determined, and pieces of
lung, liver, spleen, kidney, thymus, thyroidAKR, LEUKAEMIA AND POLYCATIONS
gland and mesenteric and peripheral lymph
nodes were taken and stained with haemato-
xylin-eosin, periodic acid-Schiff and alkaline
Congo red. Amyloid was identified by its
birefringence under crossed polars (Missmahl
and Hartwig, 1953).
RESULTS
Necropsy of the AKR mice usually
revealed enlarged thymus, spleen and
lymph nodes, elevated leucocyte counts
in peripheral blood (2 x 103/4U) and normal
haematocrit values (500%). Histology
showed leukaemic infiltrates in thymus,
thyroid, lymph nodes, spleen, liver, heart,
kidney and lung. Other mice died with
small thymus, normal-appearing organs,
normal blood value and no leukaemic infil-
trates. When amyloid was present it was
seen as patches confined to the peri-
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FIG. Risk of dying in one-month subperiods
for untreated AKR mice.
follicular area of the spleen. The kidney
glomeruli looked normal.
Experiment I
191 untreated AKR males and 191
untreated females had survival times of
9 0+2 7 (s.d.) and 9-7i2-7 months res-
pectively. The risk of dying within the
next month (dead during one month
relative to number alive at beginning of
month) increased sharply from 1% for
mice 4 months of age to 30+00 for the
9th month of life. As far as can be judged
from the small number of mice getting
older, the rate of inierease is not sustained
after the 9th month (Fig.). Fifteen per
cent of the males and 500 of the females
died without leukaemia, the mean survival
time of these groups being 9-3 and 9-4
months respectively. Most non-leukaemic
males had spleen amyloid.
Experiment II
AKR males treated with polycation as
newborn anid kept for life showed a
leukaemiaincidenceof370 (29/77)(Table),
which is significantly (P<0-001, chi-square
test) lower than the 76% (60/79) among
the MEM-treated control males and the
850o in the 191 untreated males (Table).
In contrast, the polyeation-treated males
showed an incidence of spleen amyloid of
56% (43/77) which is significantly
(P<0-001) higher than the 16% (13/79) in
control males. Amyloid was located peri-
follicularly in the spleen and was not
found in other organs. A dose-related
response with respect to both amyloid
induction and reduction in leukaemia
incidence is suggested from the DEAE-d-
treated male mice. In polycation-treated
females the leukaemia incidence was 78%
(47/60), which is also significantly
(P<0 01) less than the 96% (76/79) of
MEM-treated anduntreatedfemales. Amy-
loid does not occur in untreated AKR
females and only one case occurred in
MEM-treated females, but a few cases
appeared after polyeation treatment. Leu-
kaemic infiltrations and amyloid in the
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TABLE-Survival Time, Leukaemia Incidence and Amyloid Incidence in
Treated with Polyion as Newborn and on Days 7, 14, 21 and 28
AKR Mice
Number dying with
,-
I
Sex Treatment Charge
Male DEAE-d +
high dose
DEAE-d +
low dose
Polybrene +
Dextran 0
MEM
Untreated
D-sulph -
Total
Mean survival
inmonths ±s.d.
Female DEAE-d -
high dose
DEAE-d +
low dose
Polybrene +
Dextran 0
MEM
Untreated
D-sulph
Total
Mean survival
in months ±s.d.
Mean
survival
No. in mnonths
mice ±s.d.
30 11-0±2-7
Leukaernia
without
amyloid
(%)
3(10)
20 95±34 9(45)
27
45
79
191
25
8-4±3 -4
9-7±2-6
10-3±2-7
9-0±2 - 7
9-5±2 7
11 (41)
34 (76)
59 (74)
172 (85)
19 (76)
417 9-4+2-3 307
Amyloid
without
leukaemia
(%)
23 (77)
7 (35)
7 (26)
3(7)
12 (65)
19 (10)
0 (0)
71
Leukaemia
and
amyloid
4
1
2
1
0
0
9
No
detectable
lesion
0
3
8
6
7
10
6
40
9-7±2-2 9-7±2-9 10 1 8-5±3-1
20 9-7±2-7 15(75)
18 8 - 1±3
-3 14(77)
22
39
79
191
35
9-3±2 6
9-5±1 8
9 -63-3
9-7±2-7
9-4±2 -3
16 (73)
30 (74)
76 (96)
181 (95)
33 (95)
404 9-6±2-2 365
2
2
0
0
1
0
0
5
9-7]-2-2 11.0
1
0
0
0
0
0
2
2
1
6
9
2
10
2
32
10-5 9-4±2-4
same animal were observed in fewer cases
(001<P<0'02) than was to be expected
if the two lesions occurred independently.
The mean survival time was the same in
the different experimental groups, and
mice dying with amyloid or with no detect-
able lesion had a mean survival time not
different from that of leukaemic animals.
The graft-vs-host reaction, as measured by
the spleen index (Simonsen and Jensen,
1959) in (C3H x C57B/6)F1 mice (C3H/He
H2-K1, C57BL/6 H2-b) was not influenced
by preincubating 5 x 105 donor C57BL/6
spleen cells with polyion, 25 ,ug/in.l, 30 min,
2000, before i.v. inoculation, orbytreating
the recipients with 2-5 ,ug of polyion
daily. Survival of BALB/c (H-2d) skin
grafted on to C3H/He mice was unaffected
by daily pre-treatment of the recipients
with 250 ,ug of polyion, starting 6 days
before grafting.
Experiment III
J.p. administration of lymphoid cells
from young donors throughout life to 163
male and 170 female AKR mice had no
significant influence on the survival time
or leukaemia and amyloid incidences,
when compared with 60 males and 60
females receiving saline. Again, the mean
survival time of leukaemic and non-
leukaemic animals was the same, being 8-8
and 8-3 months respectively for females
and 8-5 and 8-7 for males, the leukaemia
incidences being 96 and 96% for females
and 68 and 74% for males.
DISCUSSION
From the striking similarity in mean
survival time of untreated AKR mice
whether dying with or without extensive
leukaemic infiltrates, and from the un-
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changed mean survival time of AKR mice
which had their leukaemia incidence
reduced either by thymectomy performed
on animals between 35 and 150 days ofage
(Nakakuki, Shisa and Nishizuka, 1967) or
by prophylactic treatment with casein
(Ebbesen, 1974a) or polycation (this
paper) we deduce that the early death of
intact AKR mice is most likely caused by
an ageing process which does not require
leukaemia for implementation.
The cause of death in non-leukaemic
animals is unresolved. The small deposits
of spleen amyloid in the males is hardly
significant, especially as the mean survival
time of non-leukaemic males with and
without amyloid was the same.
Thus we would suggest that leukaemia
is but the most conspicuous symptom of a
more basic mechanism that leads to death
even if leukaemia does not develop. A
somewhat similar situation may exist with
the long-living (CBA x DBA/2)F1 hybrids,
which show about the same mean survival
time whether dying with leukaemia or not
(Rask-Nielsen and Ebbesen, 1969).
The thymus is a key organ in
determining the time of death in AKR
mice, since thymectomy of very young
animals prolongs the survival time
(McEndy, Boon and Furth, 1944). Re-
peated grafting of lymphoid cells, as done
in the present and previous experiments
(Ebbesen and Doenhoff, 1971; Metcalf,
1962) or grafting of whole thymus (Gersh-
win et al., 1976) from young syngeneic
donors to intact recipients, does not
influence development of leukaemia or
time of death in AKR or other mice
(Albright and Makinodan, 1966). Grafting
ofthymus from old AKR donors to young
syngeneic recipients, however, does cause
early death (Gershwin et al., 1976). In
these experiments, the thymus seems to
act as an autonomous (Burnet, 1964)
positive clock. A virus may well be
involved (Waksal et al., 1976; Schafer et
al., 1977). If our assumption is correct, the
underlying cause of death must be a
hitherto unrecognized process which is
interfered with by early thymectomy and
6
immuno-chemotherapy, both ofwhich can
prolong the mean survival time (Bekesi
et al., 1976). It furthermore follows that if
death in AKR mice is accounted for by our
hypothetical mechanism, spontaneous leu-
kaemia in these animals could be a
controlled non-lethal disease.
Irrespective of the above question, the
present work also demonstrates that
cancer-prophylactic treatment is possible
with the carbohydrates DEAE-d and
dextran. The therapeutic value of the
polyeations DEAE-d and polybrene in
mice with spontaneous and virus-induced
leukaemia has been demonstrated previ-
ously (Ebbesen, 1974b).
Furthermore, our work shows, for the
first time, that simple polycations may
induce amyloid, although nearly exclus-
ively in males. Under the experimental
conditions used, spontaneous amyloid is
also confined to males (Ebbesen, 1968).
Secondary amyloid disease is known to
effect both macrophages (Teilum, 1964),
B lymphocytes (Britton, 1975) and
thymus cells (Scheinberg, Goldstein
and Cathcart, 1976). The polycations
used enhance in vitro phagocytosis
(Ryser, 1967), in vivo antibody pro-
duction (Wittman, 1970) and in vitro
immune cytolysis (Ebbesen, 1972), and
enhance casein amyloidosis (ibid.). The
graft-vs-host and skin-allograft-rejection
experiments showed no effect on these T-
cell functions. Amyloid and leukaemia
occurred again (Ebbesen and Doenhoff,
1971; Ebbesen, 1974a) as mutually ex-
clusive phenomena, but actual induction
of amyloid is not a prerequisite for the
leukaemia-preventing effect, as DEAE-d
and dextran lowered the leukaemia incid-
ence in females, with few cases of amyloid
induction.
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